Hepatocellular carcinoma in patients with thalassemia in the post-DAA era: not a disappearing entity

Ann Hematol. 2021 Jul;100(7):1907-1910. doi: 10.1007/s00277-021-04511-1. Epub 2021 Apr 13.

Authors

Paolo Ricchi¹, Silvia Costantini², Anna Spasiano², Patrizia Cinque², Simona Esposito², Aldo Filosa²

Affiliations

¹ U.O.S.D. Malattie Rare del Globulo Rosso, Azienda Ospedaliera di Rilievo Nazionale "A.Cardarelli", Via A. Cardarelli 9, 80131, Napoli, Italy. pabloricchi@libero.it.
² U.O.S.D. Malattie Rare del Globulo Rosso, Azienda Ospedaliera di Rilievo Nazionale "A.Cardarelli", Via A. Cardarelli 9, 80131, Napoli, Italy.

PMID: 33851259
DOI: 10.1007/s00277-021-04511-1

No abstract available

Publication types

Letter

MeSH terms

Carcinoma, Hepatocellular / complications*
Carcinoma, Hepatocellular / diagnosis
Carcinoma, Hepatocellular / epidemiology
Female
Humans
Italy / epidemiology
Liver Neoplasms / complications*
Liver Neoplasms / diagnosis
Liver Neoplasms / epidemiology
Male
Middle Aged
Thalassemia / complications*
Thalassemia / epidemiology